Beruflich Dokumente
Kultur Dokumente
OVERVIEW of the
presentation
overview
Health History
Physical Assessment
Anatomy and Physiology of Respiratory System
Pathophysiology of Pulmonary Tuberculosis
Disease Study
Medical Management
Nursing Management
Drug Study
Laboratory Findings
Nursing Care Plan
tuberculosis
MYCOBACTERIUM TUBERCULOSIS
DEFINITION OF TERMS
ANEMIA
CALCIFICATION
FIBROSIS
GHONS COMPLEX
GHONS TUBERCLE
HYPONATREMIA
HYPOXEMIA
METABOLIC ALKALOSIS
NECROSIS
PNEUMOTHORAX
THROMBOCYTOSIS
HEALTH HISTORY
BIOGRAPHICAL DATA
Name: Mr. X
Address: Panginay,Guiguinto, Bulacan
Birthday: August 17, 1984
Birthplace: Guiguinto, Bulacan
BIOGRAPHICAL DATA
Age:
31 years old
Occupation:
Garbage Collector
Civil Status:
Single
Religion:
Roman Catholic
BIOGRAPHICAL DATA
Nationality:
Filipino
Educational Attainment: Elementary
Graduate
Date of Admission: December 18, 2015
Date of Interview: January 15,2016
BIOGRAPHICAL DATA
HEALTH HISTORY
History of
present illness
Dr. Ramos made a referral for Surgery Department for Chest Tube
Thoracotomy. For the pharmacologic therapy, his medications
were:
HRZE tab 3tabs PC
Multi-Vitamins + Budizine tab OD
Mefenamic Acid 500mg tab q8 PRN for pain
History of
past illness
Family health
history
Parental Side
His 54 year-old father had Pulmonary Tuberculosis when he was
in secondary education and undergone treatment for 3 months.
Maternal Side
His mother is hypertensive and has asthma.
ACTIVITIES OF
DAILY LIVING
CIRCULATION
RESPIRATION
RESPIRATION
ELIMINATION
ELIMINATION
PERSONAL HYGIENE
EXERCISE
COMPETENCIES
PHYSICAL
EMOTIONAL
MENTAL
SPIRITUAL
SOCIAL
ENVIRONMENTAL
ENVIRONMENTAL
PHYSICAL ASSESSMENT
General Appearance
PHYSICAL ASSESSMENT
Vital Signs
HEAD
FACE
NECK
CHEST
ABDOMEN
GENITALIA
Not assessed.
EXTREMITIES
Upper
Both arms are symmetrical and he can move
it independently. He has a tattoo on both arms.
PHYSICAL ASSESSMENT
Lower
Both legs are symmetric in shape and length.
No problems noted.
FUNCTIONS
Nose
Nose
Mouth
PHARYNX
EPIGLOTIS
TRACHEA
LARYNX
TRACHEA
BRONCHIOLE
S
BRONCH
I
ALVEOLI
LARYNX
TRACHEA
BRONCHIOLE
S
BRONCH
I
ALVEOLI
DIAPHRAGM
pathophysiology
Risk factors
pathophysiology
pathophysiology
pathophysioloogy
pathophysioloogy
DISEASE STUDY
MODE OF TRANSMISSION
Clincal symptoms
DIAGNOSTIC findings
DIAGNOSTIC TEST
COMPLETE HISTORY
AND PHYSICAL ASSESSMENT
DIAGNOSTIC TEST
CHEST X-RAY
DIAGNOSTIC TEST
MANTOUX TEST
The Mantoux method is a standardized, intracutaneous injection procedure
and should be performed only by those trained in its administration and
reading.
Video
DIAGNOSTIC TEST
SPUTUM CULTURE
MEDICAL MANAGEMENT
MEDICAL MANAGEMENT
PHARMACOLOGIC THERAPY
NURSING MANAGEMENT
NURSING MANAGEMENT
NURSING MANAGEMENT
PROMOTING ACTIVITY
NURSING MANAGEMENT
PROMOTING NUTRITION
NURSING MANAGEMENT
NURSING MANAGEMENT
MEDICAL MANAGEMENT
(Pneumothorax)
Video assisted
thoracostomy surgery
V.A.T.S
Laboratory results
WBC
DECEMBE
R 21,
2015
12.6
RBC
5.20
4.50
4.08
4.09
3.99
4.005.50
Normal
HGB
123
107
96
95
95
120-160
Anemia
HCT
0.392
0.336
0.293
0.292
0.285
0.4400.540
Anemia
PLT
621
521
685
586
561
150-400
Thrombocytosis
TEST
NORMAL
RANGE
INTERPRETATIO
N
4.0-10.0
Infection
Blood chemistry
It is testing defined simply as identifying the numerous chemical substances
found in the blood.
Test
September
10,2015
Normal Range
Interpretation
TOTAL PROTEIN
56.1 g/dl
41.0-83.0 g/dl
Normal
ALBUMIN
31.7 g/dl
34.0-53.0 g/dl
Hypoalbumenia
Test
DECEMB
ER 21,
2015
DECEMB
ER 25,
2015
JANUARY
04, 2016
JANUARY
06, 2016
JANUARY
10, 2016
Creatini
ne
59.5
umol/L
60.9
umol/L
Sodium
123.6
mmol/L
127.7
mmol/L
121.8
mmol/L
147.7
mmol/L
Potassiu
m
4.10
mmol/L
4.15
mmol/L
4.08
mmol/L
NORMA
L
RANGE
72.0127.0
umol/L
135 to
148
mmol/l
3.5 to
5.3
mmol/l
INTERPRETATI
ON
Decreased
muscle mass
Hyponatremni
a
Normal
INTERPRETATION
Test
pH
7.50
7.35 7.45
Alkalosis
pCO2
41.7
35 45 mmHg
Normal
pO2
111.1
80 100 mmHg
Partially
Compensated
HCO2
36.0
22 26 mEq/L
Alkalosis
B.E
11.2
+/- 2 mEq/L
Metabolic Alkalosis
O2 Sat.
98.4
97%
Over Corrected
Hypoxemia
Abdominal ultrasound
It is a type of imaging test. It is used to look at organs in the abdomen,
including the liver, gallbladder, spleen, pancreas, and kidneys.
IMPRESSION:
Diffuse liver parenchymal changes
Consider renal parenchymal disease with calietasis, bilateral
Minimal ascites
Incidental note of right pleural effusion
Unremarkable gallbladder, pancreas, spleen, urinary bladder and prostate
gland
DRUG STUDY
DRUG STUDY
MEFENAMIC ACID
BRAND NAME:
Ponstel
CLASSIFICATION:
Analgesic,
Nonsteroidal AntiInflammatory
Drug (NSAID)
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
NSAID
that
inhibits
COX-1
and COX2
enzymes
necessar
y for
prostagla
ndin
synthesis
.
INDICATION
CONTRAINDICATI
ON
ADVERSE
EFFECTS
Short-term
relief of
mild to
moderate
pain.
Hypersensitivi
ty to
mefenamic; GI
inflammation,
or ulceration.
Severe
diarrhea,
nausea &
vomiting,
headache,
bleeding,
and
leukopenia
etc..
NURSING
CONSIDERATION
-Observe 10 rights
in drug
administration.
-Monitor blood
pressure during
initiation and
throughout the
course of
treatment.
-Monitor for and
report promptly S&S
of GI ulceration or
bleeding.
-Assess patients
who develop severe
diarrhea and
vomiting for
dehydration and
electrolyte
imbalance.
-Monitor lab tests:
DRUG STUDY
KETEROLAC
BRAND NAME:
Toradol
CLASSIFICATION:
Analgesic,
Nonsteroidal AntiInflammatory
Drug (NSAID);
Antipyretic
DRUG FORM:
Solution for
injection
ROUTE:
IV
ACTION
INDICATION
CONTRAINDICATI
ON
It inhibits
synthesis
of
prostagla
ndins by
inhibiting
both
COX-1
and COX2
enzymes.
Short-term
managemen
t of pain (up
to 5 days).
Contraindicate
d with
significant
renal
impairment,
aspirin allergy,
recent GI
bleed or
perforation.
Use cautiously
with impaired
hearing;
allergies;
hepatic
conditions.
ADVERSE
EFFECTS
Drowsiness,
nausea,
headache,
fatigue,
insomnia,
and
hemorrhage
etc..
NURSING
CONSIDERATION
-Observe 10 rights
in drug
administration.
-Assess first the
patient before
administering this
drug: know the
history (e.g.
allergies, renal
impairment, etc.)
and physical
condition of the
patient.
-Withhold drug and
notify prescriber if
S&S of
hypersensitivity
occur.
-Monitor for S&S of
GI distress or
bleeding including
nausea, GI pain,
diarrhea, melena, or
hematemesis.
DRUG STUDY
TRAMADOL
BRAND NAME:
Ultram
CLASSIFICATION:
Analgesic, Opiate
Agonist
DRUG FORM:
Solution for
injection
ROUTE:
IV
ACTION
INDICATION
CONTRAINDICATIO
N
ADVERSE
EFFECTS
NURSING CONSIDERATION
Centrally
acting
opiate
receptor
agonist
that
inhibits
the
uptake of
norepinep
hrine and
serotonin,
suggestin
g both
opioid and
nonopioid
mechanis
ms of pain
relief.
Managemen
t of
moderate or
moderately
severe pain.
Hypersensitivit
y to tramadol,
opioids, or any
component of
the
formulation;
opioiddependent
patients.
Dizziness,
vertigo,
fatigue,
headache,
somnolence,
constipation,
and
anaphylactic
reaction etc..
-Observe 10 rights in
drug administration.
-Monitor vital signs
and assess for
orthostatic
hypotension or signs
of CNS depression.
-Assess bowel and
bladder function;
report urinary
frequency or
retention.
-Use seizure
precautions for
patients who have a
history of seizures or
who are concurrently
using drugs that
lower the seizure
threshold.
-Monitor ambulation
and take appropriate
safety precautions.
DRUG STUDY
PARACETAMOL
BRAND NAME:
Tylenol
CLASSIFICATION:
Non-narcotic,
Analgesic,
Antipyretic
DRUG FORM:
Solution for
injection
ROUTE:
IV
ACTION
INDICATION
CONTRAINDICATIO
N
ADVERSE
EFFECTS
Reduces
fever by
acting on
the
hypothal
amus to
cause
vasodilat
ation &
sweating.
Fever
reduction.
Temporary
relief of mild
to moderate
pain.
Contraindicate
d with allergy
to
acetaminophe
n or any
component.
Nausea,
stomach
upset, skin
rash,
constipation,
tachycardia,
and dizziness
etc..
NURSING
CONSIDERATION
-Observe 10 rights
in drug
administration.
-Assess patients
fever or pain: type
of pain, location,
intensity, duration,
temperature, and
diaphoresis.
-Assess allergic
reactions: rash,
urticaria; if these
occur, drug may
have to be
discontinued.
-Teach patient to
recognize signs of
chronic overdose:
bleeding, bruising,
malaise, fever, sore
throat.
DRUG STUDY
CEFTAZIDIME
BRAND NAME:
Fortaz
CLASSIFICATION:
Antibiotic,
Cephalosporin
(third generation)
DRUG FORM:
Solution for
injection
ROUTE:
IV
ACTION
INDICATION
CONTRAINDICATIO
N
ADVERSE
EFFECTS
NURSING
CONSIDERATION
It inhibits
the final
stage of
bacterial
cell wall
synthesis
, leading
to cell
death.
To treat
infections of
lower
respiratory
tract
Hypersensitivit
y to
ceftazidime or
cephalosporin;
viral disease.
Nausea,
vomiting,
abdominal
pain, pain or
inflammation
at injection
site and
pseudomemb
ranous colitis
etc..
-Observe 10 rights
in drug
administration.
-Assess for liver and
renal dysfunction
-Do not mix with
aminoglycoside
solutions, administer
these drugs
separately.
-Be alert to onset of
rash, itching, and
dyspnea. Check
patients
temperature. If it is
elevated, suspect
onset of
hypersensitivity
reaction.
DRUG STUDY
FERROUS SULFATE
BRAND NAME:
Feosol
CLASSIFICATION:
Anti-anemic, Iron
Supplement
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
INDICATION
CONTRAINDICATIO
N
Standard
iron
preparation
that corrects
erythropoiet
ic
abnormalitie
s induced by
iron
deficiency
but does not
stimulate
erythropoies
is.
Preventio
n and
treatment
of iron
deficienc
y
anemias.
-Dietary
suppleme
nt for
iron.
Patients
receiving
repeated
blood
transfusions;
anemia not
due to iron
deficiency.
ADVERSE
EFFECTS
NURSING
CONSIDERATION
Nausea,
heartburn,
constipation,
black stools,
shock, and
cardiovascul
ar collapse
etc..
- Observe 10 rights
in drug
administration.
-Give between
meals with water
but may give with
meals if
gastrointestinal
discomfort occurs.
-Avoid simultaneous
administration of
antacids or
tetracycline.
-Monitor serum iron,
total iron- binding
capacity,
reticulocyte count,
hemoglobin, and
ferritin.
DRUG STUDY
IPRATROPIUM + SALBUTAMOL
BRAND NAME:
Combivent
CLASSIFICATION
:
Anticholinergic
DRUG FORM:
Solution for
inhalation
ROUTE:
Nasal Inhalation
ACTION
INDICATION
CONTRAINDICATI
ON
The
ipratropium
ingredient is
an
anticholinerg
ic drug which
relaxes
smooth
muscle in
the lung. The
salbutamol
ingredient is
a beta-2
agonist
which
stimulates
beta-2 sites
in the lungs
Managemen
t of
reversible
bronchospas
m
associated
with
obstructive
airway
diseases in
patients
who require
more than a
single
bronchodilat
or.
Use as
primary
treatment for
acute
episodes;
hypersensitivi
ty to
atropine,
bromides,
peanut oils,
soy lecithin.
ADVERSE
EFFECTS
Dizziness,
blurred
vision,
nausea, dry
mouth,
dyspnea,
palpitations,
and chest
pain etc..
NURSING
CONSIDERATION
- Observe 10 rights
in drug
administration.
-Monitor respiratory
status; auscultate
lungs before and
after inhalation.
-Monitor the
patient's vital signs,
noting hypotension
and an irregular or
abnormal pulse.
-Maintain a quiet,
comfortable
environment to
minimize anxiety
and perhaps
decrease
palpitations.
DRUG STUDY
ACETYLCYSTEINE
BRAND NAME:
Mucomyst
CLASSIFICATIO
N:
Mucolytic
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
INDICATION
CONTRAINDICATI
ON
Mucolytic
that
reduces the
viscosity of
pulmonary
secretions
by splitting
disulfide
linkages
between
mucoprotei
n molecular
complexes.
Adjuvant
therapy in
patients with
abnormal
mucous
secretions in
acute and
chronic
bronchopulmon
ary diseases,
and in
pulmonary
complications
of cystic
fibrosis and
surgery,
tracheostomy,
and atelectasis.
Hypersensitiv
ity to
acetylcystein
e; patients at
risk of gastric
hemorrhage.
ADVERSE
EFFECTS
Dizziness,
nausea,
vomiting,
stomatitis,
burning
sensation in
upper
respiratory
passages,
and
epistaxis.
NURSING
CONSIDERATION
-Observe 10 rights
in drug
administration.
-Monitor for S&S of
aspiration of excess
secretions, and for
bronchospasm.
-Monitor lab tests:
ABGs, pulmonary
functions and pulse
oximetry as
indicated.
DRUG STUDY
AZITHROMYCIN
Azithromycin
Doctors Order: Azithromycin 500mg tab OD
.
BRAND NAME:
Zithromax
CLASSIFICATIO
N:
Macrolide,
Antibiotic
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
A macrolide
antibiotic
that
reversibly
binds to the
50S
ribosomal
subunit of
susceptible
organisms
and
consequentl
y inhibits
protein
synthesis,
causing cell
death.
INDICATION
CONTRAINDICATI
ON
ADVERSE
EFFECTS
NURSING
CONSIDERATION
Treatment for
pneumonia,
lower
respiratory
tract
infections.
Hypersensitiv
ity to
azithromycin,
erythromycin
, or any of
the macrolide
antibiotics;
history of
cholestatic
jaundice/hep
atic
dysfunction
associated
with prior use
of
azithromycin.
Nausea and
vomiting,
headache,
dizziness,
fatigue, and
hepatotoxicit
y etc..
-Observe 10 rights
in drug
administration.
-Administer on an
empty stomach 1 hr
before or 23 hr
after meals. Food
affects the
absorption of this
drug.
-Report immediately
any S&S of
hypersensitivity;
though rare, these
reactions can be
serious.
DRUG STUDY
HREZ
RIFAMPICIN
Doctors Order: HRZE 3 tabs OD
BRAND NAME:
Crisarfam
CLASSIFICATI
ON:
Anti-infective
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
Inhibits DNAdependent
polymerase,
decreases
replication.
INDICATION
CONTRAINDICATI
ON
ADVERSE
EFFECTS
NURSING
CONSIDERATION
Maintenance
phase
treatment of
all forms of
pulmonary and
extrapulmonary TB;
prevention of
meningococcal
meningitis.
Jaundice
associated
with reduced
bilirubin
excretion; 1st
trimester
ofpregnancy;
premature
and newborn
infants. Druginduced
liverdiseases,
impaired liver
function.
GI
disturban
ce,
nausea
and
vomiting,
diarrhea,
SOB, GI
bleeding,
liver and
kidney
dysfuncti
on etc..
-Observe 10
rights in drug
administration.
-Assess lung
sounds, character
and amount of
sputum
periodically.
-Monitor patient
compliance with
treatment
regimen.
-Inform patient
that this
medication will
discolor urine,
stool, saliva,
tears, sweat, and
otherbody fluid a
red-brown color.
ISONIAZID
Doctors Order: HRZE 3 tabs OD
BRAND NAME:
Norvit
CLASSIFICATI
ON:
Anti-infective
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
INDICATION
CONTRAINDICATI
ON
ADVERSE
EFFECTS
NURSING
CONSIDERATION
Inhibits RNA
synthesis,
decreases tubercle
bacilli replication.
Treatment for
pulmonary and
extrapulmonary
tuberculosis.
Should not be
given to
patients with
drug-induced
liver disease.
Various
skin
eruptions,
nausea
and
vomiting,
liver
dysfuncti
on, and GI
disturban
ce etc..
-Observe 10
rights in drug
administration.
-Monitor
renal/liver
function.
-Instruct patient
that compliance
with dosage
schedule for
duration is
necessary to gain
benefits.
-Advice patient to
report peripheral
neuritis.
PYrazinamide
Doctors Order: HRZE 3 tabs OD
BRAND NAME:
Myocovak
CLASSIFICATI
ON:
Anti-infective
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
INDICATION
CONTRAINDICATIO
N
ADVERSE
EFFECTS
Mechanism is
unknown, highly
specific and
bactericidal
forMycobacterium
tuberculosis
hominis.
Treatment
for active
tuberculosis
in adults
and
selected
children.
Acuteliverdisease,
porphyria,
peripheral
neuritis, acute
gout,
hypersensitivit
y and
pregnancy.
Nausea and
vomiting,
thrombocyt
openia,
anorexia,
doserelated
hepatotoxic
ity and
increased
serum iron
concentrati
on.
NURSING
CONSIDERATION
-Observe 10
rights in drug
administration.
-Assess patients
condition before
therapy and
regularly
thereafter to
monitor drug
effectiveness.
-Regularly assess
for hepatoxicity.
-Regularly assess
renal status.
-Instruct patient
to take drug
continuously as
prescribed.
ETHAMBUTOL
Doctors Order : HRZE 3 tabs OD
BRAND NAME:
Odetol
CLASSIFICATI
ON:
Anti-infective
DRUG FORM:
Tablet
ROUTE:
PO
ACTION
It suppresses
the growth of
tubercle bacilli
however the
specific
mechanism
ofaction is
unknown.
INDICATION
CONTRAINDICATIO
N
Patients with
optic neuritis.
Should
generally not
be used in
children below
6 years ofage.
ADVERSE
EFFECTS
Reduction
in visual
acuity,
retinal
hemorrhag
e, skin
rashes,
pruritus,
fever, and
joint pain
etc..
NURSING
CONSIDERATION
-Observe 10 rights
in drug
administration.
-Perform visual
acuity and
colordiscriminatio
n tests before and
during therapy.
-Assess liver
adrenal status and
function before
and during therapy.
-Advise patient
that compliance
with dosage
schedule and
duration is
necessary to
eradicate disease.